Natixis Advisors LLC raised its stake in shares of Koninklijke Philips (NYSE:PHG – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 741,277 shares of the technology company’s stock after buying an additional 26,227 shares during the quarter. Natixis Advisors LLC owned about 0.08% of Koninklijke Philips worth $18,769,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the stock. Brandes Investment Partners LP grew its holdings in Koninklijke Philips by 4.9% during the 4th quarter. Brandes Investment Partners LP now owns 918,635 shares of the technology company’s stock valued at $23,260,000 after buying an additional 43,157 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Koninklijke Philips by 87.7% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock worth $56,266,000 after purchasing an additional 1,038,321 shares during the period. Avantax Advisory Services Inc. lifted its stake in shares of Koninklijke Philips by 23.7% during the 4th quarter. Avantax Advisory Services Inc. now owns 11,575 shares of the technology company’s stock worth $293,000 after purchasing an additional 2,219 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of Koninklijke Philips by 4.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 8,932 shares of the technology company’s stock worth $226,000 after purchasing an additional 384 shares during the period. Institutional investors and hedge funds own 13.67% of the company’s stock.
Koninklijke Philips Trading Down 2.0 %
Shares of PHG opened at $26.30 on Wednesday. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $24.72 billion, a P/E ratio of -31.30, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78. The stock’s fifty day simple moving average is $26.70 and its 200 day simple moving average is $27.79. Koninklijke Philips has a twelve month low of $19.10 and a twelve month high of $32.91.
Koninklijke Philips Cuts Dividend
The company also recently announced an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be given a $0.886 dividend. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio (DPR) is currently -89.29%.
Analysts Set New Price Targets
A number of research analysts have weighed in on the company. StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, March 8th. BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. Finally, UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy”.
Get Our Latest Analysis on PHG
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- How to Evaluate a Stock Before Buying
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Dividend Payout Ratio Calculator
- 3 Must-Own Stocks to Build Wealth This Decade
- What is a Bond Market Holiday? How to Invest and Trade
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.